These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19377996)

  • 1. Locked nucleic acid aptamers.
    Barciszewski J; Medgaard M; Koch T; Kurreck J; Erdmann VA
    Methods Mol Biol; 2009; 535():165-86. PubMed ID: 19377996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locked nucleic acid nucleoside triphosphates and polymerases: on the way towards evolution of LNA aptamers.
    Veedu RN; Wengel J
    Mol Biosyst; 2009 Aug; 5(8):787-92. PubMed ID: 19603111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology and aptamers: applications in drug delivery.
    Levy-Nissenbaum E; Radovic-Moreno AF; Wang AZ; Langer R; Farokhzad OC
    Trends Biotechnol; 2008 Aug; 26(8):442-9. PubMed ID: 18571753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
    Veedu RN; Wengel J
    Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of an LNA-modified ricin RNA aptamer.
    Förster C; Zydek M; Rothkegel M; Wu Z; Gallin C; Geßner R; Lisdat F; Fürste JP
    Biochem Biophys Res Commun; 2012 Mar; 419(1):60-5. PubMed ID: 22326915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.
    Lebars I; Richard T; Di Primo C; Toulmé JJ
    Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of affinity constants of locked nucleic acid (LNA) and DNA duplex formation using label free sensor technology.
    Möhrle BP; Kumpf M; Gauglitz G
    Analyst; 2005 Dec; 130(12):1634-8. PubMed ID: 16284662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA.
    Vester B; Wengel J
    Biochemistry; 2004 Oct; 43(42):13233-41. PubMed ID: 15491130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial synthesis of thrombin-binding aptamers containing iso-guanine.
    Nallagatla SR; Heuberger B; Haque A; Switzer C
    J Comb Chem; 2009; 11(3):364-9. PubMed ID: 19243167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy progress and prospects: RNA aptamers.
    Que-Gewirth NS; Sullenger BA
    Gene Ther; 2007 Feb; 14(4):283-91. PubMed ID: 17279100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.
    Schmidt KS; Borkowski S; Kurreck J; Stephens AW; Bald R; Hecht M; Friebe M; Dinkelborg L; Erdmann VA
    Nucleic Acids Res; 2004; 32(19):5757-65. PubMed ID: 15509871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides.
    Darfeuille F; Reigadas S; Hansen JB; Orum H; Di Primo C; Toulmé JJ
    Biochemistry; 2006 Oct; 45(39):12076-82. PubMed ID: 17002307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals.
    Campbell MA; Wengel J
    Chem Soc Rev; 2011 Dec; 40(12):5680-9. PubMed ID: 21556437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid aptamers in human viral disease.
    Zhang Z; Blank M; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):307-15. PubMed ID: 15507871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions.
    Di Primo C; Dausse E; Toulmé JJ
    Methods Mol Biol; 2011; 764():279-300. PubMed ID: 21748648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional detection of proteins by caged aptamers.
    Pinto A; Lennarz S; Rodrigues-Correia A; Heckel A; O'Sullivan CK; Mayer G
    ACS Chem Biol; 2012 Feb; 7(2):360-6. PubMed ID: 22070344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and testing of aptamers for cancer.
    Barbas AS; White RR
    Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aptamers against extracellular targets for in vivo applications.
    Pestourie C; Tavitian B; Duconge F
    Biochimie; 2005; 87(9-10):921-30. PubMed ID: 15963620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamers--basic research, drug development, and clinical applications.
    Proske D; Blank M; Buhmann R; Resch A
    Appl Microbiol Biotechnol; 2005 Dec; 69(4):367-74. PubMed ID: 16283295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.